BTX-A51

A First-In-Human, Open-Label, Escalating Multiple-Dose Study to Evaluate the Safety, Toxicity, and Pharmacokinetics of BTX-A51 Capsules Alone and in Combination With Azacitidine in Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Near Add Your Location

Sorting 9 by

MDS Center of Excellence

  • Accepting patients
  • Show Principal Investigator

MDS Center of Excellence

  • Accepting patients
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials

MDS Center of Excellence

  • Accepting patients
  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator
Memorial Sloan Kettering Nassau
Uniondale, NY
Limited Activities
  • Accepting patients
  • Show Principal Investigator
Memorial Sloan Kettering Westchester
West Harrison, NY
Limited Activities
  • Accepting patients
  • Show Principal Investigator
518 hidden based on your filters. Show All

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.